BRD4 and cancer: Here, we review several specific PTMs of BRD4 and show how these modifications can modulate BRD4 to produce different results, pointing to potential targets that could not only help design more effective anticancer treatment strategies but also selectively turn off the carcinogenic activity of BRD4 in cancer cells.